ESMO 2017
Strong Support for Docetaxel-Based Triplet in Resectable Gastric Cancer
Docetaxel-based triple therapy is superior to standard therapy for patients with resectable esophagogastric cancer, ...
OCTOBER 30, 2017
Early Data: IL-10 + Nivolumab May Improve Efficacy in Renal Cancer
Combining a pegylated interleukin-10 and an anti–PD-1 led to a partial response in 41% of patients with renal ...
OCTOBER 20, 2017
Cabozantinib Improves PFS in Advanced RCC
Cabozantinib can improve PFS in patients with previously untreated advanced or metastatic RCC, according to updated ...
SEPTEMBER 21, 2017
Nivolumab-Ipilimumab Combo Beneficial in Advanced RCC
The combination of nivolumab and ipilimumab improved OS over sunitinib in patients with previously untreated ...
SEPTEMBER 20, 2017
Load more